Haitao Ran

机构：Dalian Medical University, Chengdu University of Technology, Second Affiliated Hospital of Chongqing Medical University, Chongqing Emergency Medical Center, Helix (United States), Chongqing Medical University · ORCID：0000-0001-6930-3665

发表论文 149 篇 · 总被引 6026 次 · h-index 44

代表论文

• ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling (2022 · Journal of Nanobiotechnology · 被引 132)
• Metal-ion-chelating phenylalanine nanostructures reverse immune dysfunction and sensitize breast tumour to immune checkpoint blockade (2024 · Nature Nanotechnology · 被引 74)
• Near‐Infrared II Nanoadjuvant‐Mediated Chemodynamic, Photodynamic, and Photothermal Therapy Combines Immunogenic Cell Death with PD‐L1 Blockade to Enhance Antitumor Immunity (2022 · Small · 被引 74)
• A Fibrin Site‐Specific Nanoprobe for Imaging Fibrin‐Rich Thrombi and Preventing Thrombus Formation in Venous Vessels (2022 · Advanced Materials · 被引 33)
• Ultrasound-based deep learning in the establishment of a breast lesion risk stratification system: a multicenter study (2022 · European Radiology · 被引 28)
• Real-time monitoring of NIR-triggered drug release from phase-changeable nanodroplets by photoacoustic/ultrasound imaging (2023 · Photoacoustics · 被引 27)